POPULARITY
Autonomous vehicles may be the closest real-world example of AI operating in life-and-death situations at scale. Justin Norden believes healthcare has a lot to learn from how that industry approached safety, testing, adoption, and trust. This week, Michael and Halle sit down with the founder and CEO of Qualified Health, fresh off the company's $125 million Series B, to discuss why healthcare organizations need to think differently about deploying AI. Justin shares how his experience at Stanford, Apple, Waymo, and in healthcare investing shaped his view that health systems need AI infrastructure, governance, and workforce buy-in, not just another point solution.We cover:What healthcare can learn from Waymo's approach to safe AI deploymentWhat founders need to understand about building around EpicWhy health systems need to treat AI as a CEO-level priority, not an innovation projectHow Qualified Health is helping systems deploy, monitor, and measure AI workflowsWhy governance, safety, and ROI matter as much as model performanceWhy clinicians are right to be skeptical about AI liabilityAbout our guest:Justin Norden, MD is Co-Founder and CEO of Qualified Health building the trusted platform for health system AI. Additionally, he has been an Adjunct Professor at Stanford Medicine in the Department of Biomedical Informatics Research where his research and teaching focused on AI in medicine and digital health where he founded and still teaches courses on digital health and generative AI in medicine. Previously, Dr. Norden was Co-Founder and CEO of Trustworthy AI, a company focused on algorithm safety and trust, which was acquired by Waymo (Google Self-Driving). He was a Partner at GSR Ventures leading investments in healthcare and AI, worked on the healthcare team at Apple, and helped start the Stanford Center for Digital Health. Dr. Justin Norden received an MD and MBA from Stanford University, an MPhil in Computational Biology from the University of Cambridge, and a BA in Computer Science from Carleton College.—
Send us Fan MailFor decades, agriculture and energy were treated as separate worlds. But what happens when farms become part of the global energy infrastructure? Ofer Haviv joins us to discuss the rise of castor as a next-generation industrial crop, the future of sustainable aviation fuel, and how AI-driven biology is transforming agriculture itself.Ofer Haviv is CEO of Casterra ( https://casterra.co/ ) and longtime President and CEO of Evogene ( https://evogene.com/ ), one of the pioneers in computational biology and AI-driven agricultural innovation.For more than two decades, Ofer has helped lead the transformation of crop science from traditional breeding into a data-driven discipline powered by predictive biology, artificial intelligence, and advanced genomics. He played a key role in Evogene's spin-off from Compugen in 2002 and has guided the company through its evolution into a global computational biology platform with applications spanning agriculture, human health, industrial biotechnology, and sustainable materials.Today, Ofer also serves as CEO of Casterra, an Evogene subsidiary focused on transforming castor farming into a scalable industrial platform for the future bioeconomy. Through elite castor seed varieties and integrated farming solutions, Casterra is helping address growing global demand for sustainable feedstocks used in biofuels, aviation fuel, lubricants, polymers, cosmetics, and other bio-based industries.With increasing pressure on the world to decarbonize transportation, strengthen energy security, and develop more sustainable industrial supply chains, Casterra's work sits at the convergence of agriculture, climate technology, and renewable energy innovation.Ofer holds a degree in Economics and Accounting from Tel Aviv University and is a Certified Public Accountant in Israel.#OferHaviv #Casterra #Evogene #Biofuels #SustainableAviationFuel #SAF #ClimateTech #Agriculture #AgTech #Biotech #AI #ArtificialIntelligence #ComputationalBiology #RenewableEnergy #GreenEnergy #FutureOfEnergy #IndustrialBiotech #Castor #SustainableFarming #EnergyTransition #Bioeconomy #CarbonNeutral #FutureTech #ClimateInnovation #CleanTech #Aviation #JetFuel #SustainableTechnology #FoodTech #PrecisionAgricultureSupport the show
Most bench scientists think breaking into computational biology means going back to school. Dean Lee proves otherwise. Dean went from neuroscience PhD student at Harvard to Principal Computational Biologist at Novartis by teaching himself to analyze scRNA-seq data in stolen scraps of time alongside his bench job, and now he helps thousands of scientists make the same move through his online community Dean's List.In this episode, Dean and Carina break down exactly what it takes to build real computational biology credibility without another degree, without quitting your job, and without waiting for someone to hand you permission.You'll learn:Why Coursera certificates don't move hiring managers and what actually doesHow to find public biological data and build your first comp bio project this weekThe reproducibility strategy: why re-analyzing a published Nature paper is an industry skill and your best portfolio move at the same timeHow to pitch yourself as a funded intern through the Massachusetts Life Sciences Center to break into small biotech startupsThe state of entry-level comp bio hiring in 2026 and where the openings actually areHow to frame volunteer work and self-directed projects on your resume so hiring managers take them seriouslyWhether you've been thinking about this pivot for years or you're just starting to wonder if it's possible, this conversation gives you the roadmap.RNA-Seq and ScRNA-Seq CoursesHow to become a computational biologist in a year The Big Challenge... With Dean LeeDean's ListLink In with Dean!Learn more about the Collaboratory Career Hub community and access our free resources:Join our Skool CommunityTake the Free 7-day Interview Sprint ChallengeCheck out our sister podcast: Building BiotechsSend Carina a connection request on LinkedIn!Stay connected with us:
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into some of the most compelling stories and trends shaping the industry. Daiichi Sankyo has unveiled a bold five-year business plan with an eye on rising to become a top-five global oncology leader by 2035. This ambition is driven by a $1.3 billion initiative focused on antibody-drug conjugates, or ADCs, which are targeted cancer therapies. These plans highlight a strategic emphasis on oncology and operational efficiencies designed to maintain competitive advantage in a rapidly evolving market. Meanwhile, CSL Limited faces a more challenging landscape, adjusting its revenue projections and facing a significant impairment related to its acquisition of Vifor Pharma. These financial challenges underline the risks inherent in large-scale acquisitions within the pharmaceutical sector, necessitating a reassessment of strategic priorities and investments in R&D. Regulatory developments continue to be pivotal, with Partner Therapeutics' bispecific antibody Bizengri gaining FDA national priority designation for rare bile duct cancer. This underscores the FDA's dedication to expediting critical therapies through its National Priority Pilot program, aiming to bring life-saving treatments to underserved populations quickly. However, regulatory uncertainty looms with President Donald Trump's reported plan to dismiss FDA Commissioner Marty Makary, which could impact the agency's leadership and agenda. Additionally, a Supreme Court ruling has temporarily reinstated telemedicine access to mifepristone, an abortion pill, spotlighting the ongoing debates about reproductive healthcare accessibility through telemedicine. In research news, Novo Nordisk's collaboration with an AI biotech firm marks a strategic shift aimed at rescuing its Parkinson's cell therapy program. This partnership highlights the increasing role of artificial intelligence in drug development, particularly for revitalizing stalled projects using advanced technological applications. On the clinical trial front, Inhibrx's midphase results are promising for their OX40 agonist combined with Merck's Keytruda, showing doubled response rates in cancer patients. Such advancements underscore the potential of combination therapies in oncology and are likely to draw more investment interest from major players like Merck. Amgen's investment in a quantum technology firm poised for an IPO represents another exciting frontier. The application of quantum computing in drug discovery could revolutionize computational biology by accelerating therapeutic discoveries and improving precision medicine approaches. The biotech sector is also seeing financial maneuvers with quantum tech firms planning IPOs following investments from companies like Amgen. This signals a growing interest in leveraging quantum technology for breakthroughs in drug discovery. In Alzheimer's research, a novel gene therapy study presents an innovative method for clearing amyloid plaques from mouse brains without crossing the blood-brain barrier. By sending a protective gene to the liver, researchers achieved systemic plaque clearance—an approach that could revolutionize treatment strategies if successful in human trials. A new development in diagnostics involves a blood test predicting patient responses to GLP-1 receptor agonists like Ozempic and Wegovy. As these drugs become popular for weight management, such diagnostics could optimize outcomes by identifying patients most likely to benefit. Omada Health reported a 42% revenue increase in Q1, reflecting the expanding digital health solutions market. Their collaboration with Eli Lilly's employer weight loss program indicates rising demand for comprehensive health strategies integrating pharmacotherapy and digital health platforms. Overall, thSupport the show
In this week's episode, both of our storytellers build shields to protect themselves and discover what happens when those defences fail.Part 1: As a lonely teenager searching for connection, Christopher Moncayo-Torres turns to an unlikely disguise—a giant Clifford costume—in hopes of bridging the gap between himself and the world around him.Part 2: JP Flores has always been the family's “smart kid,” a role that becomes his armor in college—until the pressure of living up to that identity begins to crack.Christopher Moncayo-Torres is an Ecuadorian-American writer, actor, teaching artist and live storyteller, born and bred in Queens, NY, and new-ish to living in LA. Most recently, he performed alongside his Ecuadorian father (yes, really) in "No Sabo", an award-winning, solo-ish show about rekindling their once estranged relationship, despite their language barrier. He's now working on a live-ish cooking show with his mother. He also hosts the monthly storytelling-workshop show, Fail Better Story Time at Studious Coworking Space in LA's Chinatown. More info can be found at www.failbetterarts.com He's an instructor and host for The Moth. He's also a 3x Moth StorySLAM winner who has been featured on The Moth Radio Hour podcast.JP Flores recently completed his PhD in Bioinformatics and Computational Biology from UNC Chapel Hill, where he studied how DNA folds in 3D space to control when, where, and why genes turn on. He calls this the origami of gene regulation. Originally from Los Angeles, he's also pursuing a Graduate Certificate in Innovation for the Public Good, blending his love for bridging science and society. He's a HHMI Gilliam Fellow, a podcast host (From Where Does It STEM?, a Spotify Next Wave Award winner), and is passionate about turning science communication into community connection. He is also a co-founder of the nonprofit organization, Science For Good. Outside the lab, JP plays guitar and gigs around North Carolina, and lives with his very opinionated and stubborn wiener dog, Vienna. As a first-gen college student, he's driven to make science more community-centered and for the public good.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
AI is now good enough to change how computational biology teams actually work, but most companies are still adopting it like it's 2023. Sonia Timberlake, R&D strategy consultant for Timberlake & Maclsaac Biopharma Consulting, speaks with host Eleanor Howe about what's real: agentic coding, high-throughput data workflows, and the practical limits that still slow teams down. Timberlake digs into benchmarks for capabilities and end-to-end tasks, as well as multimodal chart understanding, source verification, and where human review remains non-negotiable. The conversation also explores beyond AI to what biopharma risks missing, why novel targets still matter, and where investment interest is clustering right now. Plus, tune in to get a preview of Timberlake's workshop at Bio-IT World Conference & Expo in Boston next month! If this helped you think more clearly about AI in drug development and computational biology, subscribe, share the show with a colleague, and leave a review so more builders can find the conversation. Links from this episode: Workshop: AI Upskilling for Computational Biology Teams Bio-IT World BioTeam Diamond Age Data Science Bio-IT World's Trends from the Trenches podcast delivers your insider's look at the science, technology, and executive trends driving the life sciences through conversations with industry leaders.
Matt is a Principal Computational Scientist at The Jackson Laboratory. Trained as a mathematician, Matt then moved into the area of systems biology - driven by a lifelong curiosity and the opportune timing of the 2009 financial crisis. He is currently working on two main projects: studying aging biology and understanding mechanisms of cardiotoxicity for drugs. This conversation was recorded in March 2026 ~~~~~The Maine Science Podcast is a production of the Maine Discovery Museum. It is recorded at Discovery Studios, at the Maine Discovery Museum, in Bangor, ME. The Maine Science Podcast is hosted and executive produced by Kate Dickerson; edited and produced by Scott Loiselle. The Discover Maine theme was composed and performed by Nick Parker. To support our work: https://www.mainediscoverymuseum.org/donate. Find us online:Maine Discovery MuseumMaine Discovery Museum on social media: Facebook Instagram LinkedIn Bluesky YouTubeMaine Science Podcast on social media: Facebook Instagram YouTubeMaine Science Festival on social media: Facebook Instagram LinkedIn YouTube© 2026 Maine Discovery Museum
As digital change accelerates across healthcare, payors face an urgent need to modernize how they communicate, educate, and engage. The AI-Orchestrated Experiences portfolio from Adobe and IBM represents a new paradigm where data, design, and intelligence work seamlessly together to improve outcomes for every stakeholder. In this episode of the AI at Health series on The Beat Podcast, host Sandy Vance sits down with Melissa Geissler, Partner for Healthcare and Life Sciences Strategy and Transformation at IBM, and Ted Roman, Healthcare and Life Sciences Digital Strategy Principal at Adobe, to unpack one of the most exciting partnerships in healthcare AI right now. Together, IBM and Adobe are building AI-orchestrated experience solutions that help payers deliver personalized, seamless, and scalable member experiences without the white-glove price tag. From helping members find the right health plan to automating prior authorization and appointment booking, this episode is a must-listen for any payer, provider, or health tech leader who wants to understand where consumer experience in healthcare is headed next. In this episode, they talk about: Healthcare is data-rich, but still behind every major retailer when it comes to personalized member experiences IBM and Adobe are combining platform capabilities, agentic AI, and change management into one integrated framework AI agents can now handle health plan selection, appointment booking, and benefits navigation for members Brokers serving small and mid-size employers are one of the most underserved audiences in healthcare technology The best AI strategy starts with defining the business problem first, then building the technology around it Social determinants of health data can now be integrated into personalized member recommendations Organizations that feel under-resourced are the ideal candidates for AI-orchestrated experiences The partnership is already live with clients and expanding into provider and life sciences use cases A Little About Ted and Melissa: Ted Roman, PhD, brings over a decade of expertise in healthcare and life sciences research, management, technology, operations, and digital strategy to Adobe. He is a principal in the Digital Strategy Group, serving organizations globally pursuing more interconnected experiences. Prior to Adobe, Ted served the needs of Highmark Health and McKinsey & Company's clients. He holds a PhD in Computational Biology from the School of Computer Science at Carnegie Mellon University. He also earned bachelor's degrees in computer science and mathematics from Case Western Reserve University. Melissa Geissle is a Partner at IBM, leading Public Market activities, where she applies experience strategy and service design to solve complex innovation challenges and leads a diverse team of designers, researchers, analysts, and strategists to help organizations create meaningful stakeholder connections while improving market outcomes. Over two decades, she has partnered with healthcare, life sciences, government, and nonprofit organizations to define and execute digital health initiatives, applying data-driven insights and ecosystem platform capabilities to redefine strategic marketing, service, and digital engagement functions. Melissa holds a BA in Economics from Bates College and an MBA from Georgetown University's McDonough School of Business, and has participated in global corporate citizenship initiatives across the UK, South Africa, and Poland.
A meningitis outbreak is sparking a massive media fear campaign reminiscent of the early days of the COVID-19 pandemic – but Dr. Jessica Rose warns “don't just get in line like you did last time, please.” The computational biologist and immunologist warns that the public is being driven toward MenB vaccines that carry significant, underreported risks. By analyzing VAERS data and the recombinant technology inside these injections, Dr. Rose exposes the dangers of “molecular mimicry” and explains why injecting synthetic lipoproteins could trigger severe autoimmune responses. Internet pioneer and investigative author Ken McCarthy breaks down the historical and ongoing corruption of the medical industry. Dr. Izabella Wentz, acclaimed author of Hashimoto's Thyroiditis, shares her expertise on combating the rise of medically-induced and environmentally-triggered autoimmune conditions, offering root-cause solutions for mystery illnesses. Dr. Jessica Rose is a Canadian researcher with a Bachelor's in Applied Mathematics and a Master's in Immunology from Memorial University of Newfoundland. She holds a PhD in Computational Biology from Bar Ilan University and completed postdoctoral research in Molecular Biology and Biochemistry. Find her at https://jessicasuniverse.com and follow at https://x.com/JesslovesMJK Ken McCarthy was one of the early pioneers of the movement to commercialize the Internet. Time Magazine credits him with being the first person to articulate the importance of “click-through rate” as a key metric. He's the author of over 10 books, including the bestselling What the Nurses Saw. Learn more at https://BrasscheckBooks.com and https://kenmccarthy.com Dr. Izabella Wentz, PharmD, FASCP is an internationally acclaimed thyroid specialist and licensed pharmacist who has dedicated her career to addressing the root causes of autoimmune thyroid disease, fatigue and mystery illnesses after being diagnosed with Hashimoto's thyroiditis in 2009. She received the PharmD. Degree (Doctor of Pharmacy) from the Midwestern University Chicago College of Pharmacy at the age of 23. Dr. Wentz is the author of the #1 NYT bestseller “Hashimoto's Protocol” and multiple others. Learn more at https://thyroidpharmacist.com 「 SUPPORT OUR SPONSORS 」 • STRONG CELL – If you want to feel more like your younger self, go to https://strongcell.com/ and use code DREW for 20% off. • AUGUSTA PRECIOUS METALS – Thousands of Americans are moving portions of their retirement into physical gold & silver. Learn more in this 3-minute report from our friends at Augusta Precious Metals: https://drdrew.com/gold or text DREW to 35052 • FATTY15 – The future of essential fatty acids is here! Strengthen your cells against age-related breakdown with Fatty15. Get 15% off a 90-day Starter Kit Subscription at https://drdrew.com/fatty15 • PALEOVALLEY - "Paleovalley has a wide variety of extraordinary products that are both healthful and delicious,” says Dr. Drew. "I am a huge fan of this brand and know you'll love it too!” Get 15% off your first order at https://drdrew.com/paleovalley • THE WELLNESS COMPANY - Counteract harmful spike proteins with TWC's Signature Series Spike Support Formula containing nattokinase and selenium. Learn more about TWC's supplements at https://twc.health/drew 「 ABOUT THE SHOW 」 This show is for entertainment and/or informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment. Executive Producers • Kaleb Nation - https://kalebnation.com • Susan Pinsky - https://x.com/firstladyoflove Content Producer • Emily Barsh - https://x.com/emilytvproducer Hosted By • Dr. Drew Pinsky - https://x.com/drdrew Learn more about your ad choices. Visit megaphone.fm/adchoices
Dr. Jessica Rose, PhD, MSc, BSc, is a Senior Fellow specializing in Computational Biology from Canada. She holds a Bachelor's Degree in applied mathematics and a master's degree in Immunology from Memorial University of Newfoundland, and a PhD in Computational Biology from Bar Ilan University. Dr. Rose has completed two post-doctoral degrees in Molecular Biology from the Hebrew University of Jerusalem, and in Biochemistry from the Technion Institute of Technology. She is best known for her contributions to public health and safety related to the COVID-19 injectable products, and her analyses of pharmacovigilance databases like VAERS. In this episode, Drs. Brian and Jessica talk about… (00:00) Intro (04:57) Dr. Jessica's upbringing, personality, and scientific pursuits (09:41) Covid vaccines, natural immunity, and bodily autonomy of individuals (19:50) The research of Kevin McKernan on DNA in vials of COVID-19 vaccines (27:39) The composition and production of Covid mRNA vaccines (33:04) National health regulation agencies and Covid vaccine DNA contamination (35:54) Lipid nanoparticles in mRNA vaccines and how they impact human health (44:22) Vaccine injuries due to spike protein proliferation and how the spike protein ruins the human immune system (54:38) Spike protein detox therapies (01:01:12) Fascia release (01:03:07) Cholesterol, gal bladder health, and nutrition (01:07:54) Fasting, autophogy, and the microbiome (01:11:33) Peer review and post-peer review attacks on valid research (01:21:53) Outro For more information, please see the links below. Thank you for listening! Links: Resources Mentioned in this Episode: Jules Horn (Fascia Release): https://www.youtube.com/@Jules_horn Science Guardians (post-peer review group): https://x.com/SciGuardians Dr. Jessica Rose: Research: https://www.researchgate.net/profile/Jessica-Rose-24 Why does DNA remain in vials of COVID-19 mRNA Shots?: https://rumble.com/v74rdvs-why-does-dna-remain-in-vials-of-covid-19-mrna-shots.html What Jessica Rose Knows: Dr. Jessica Rose on DarkHorse: https://rumble.com/v5q0zl8-what-jessica-rose-knows-dr.-jessica-rose-on-darkhorse.html Dr. Brian Lenzkes: Arizona Metabolic Health: https://arizonametabolichealth.com/ Low Carb MD Podcast: https://www.lowcarbmd.com/ HLTH Code: HLTH Code Promo Code: METHEALTH • • HLTH Code Website: https://gethlth.com
As the new year settles in, the industry is anticipating new innovative biotech and learning from past failures. John Keilty, venture partner at Third Rock Ventures, discusses the current trends he sees in biopharma investment, separating the hype from reality of AI (and if the AI bubble will eventually pop), other ventures that should be considered, and how new companies are being built today compared to past years in this episode of Trends from the Trenches. With host Eleanor Howe, founder and CEO of Diamond Age Data Science, Keilty also reflects on the biotech failures of past years and shares his thoughts on the role of computational biologists these days, as well as where bioinvesting is working and not working now. Links from this episode: Bio-IT World BioTeam Bio-IT World Europe Diamond Age Data Science Third Rock Ventures Bio-IT World's Trends from the Trenches podcast delivers your insider's look at the science, technology, and executive trends driving the life sciences through conversations with industry leaders.
Bioinformatics, also known as computational biology, links biological data with information storage, distribution and analysis to support many scientific research areas. In the latest Short Talks from the Hill, assistant professor Aranyak Goswami discusses how he's using computers to answer complex biological questions.
Send us a textDr. Julia Moore Vogel, PhD, MBA is Assistant Professor and Senior Program Director at The Scripps Research Institute ( https://www.scripps.edu/science-and-medicine/translational-institute/about/people/julia-moore-vogel/ ) where she is responsible for managing a broad portfolio of patient-centric health research studies, including The Long COVID Treatment Trial ( https://longcovid.scripps.edu/locitt-t/ ), a fully remote, randomized, placebo-controlled clinical trial targeting individuals with long COVID, testing whether the drug Tirzepatide can reduce or alleviate symptoms of long COVID. Prior to this current role, Dr. Vogel managed The Participant Center (TPC) for the NIH All of Us Research Program ( https://www.scripps.edu/science-and-medicine/translational-institute/translational-research/precision-medicine/index.html ) which was charged with recruiting and retaining 350,000 individuals that represent the diversity of the United States. TPC aims to make it possible for interested individuals anywhere in the US to become active participants, for example by collaborating with numerous outreach partners to raise awareness, collecting biosamples nationwide, returning participants' results and developing self-guided workflows that enable participants to join whenever is convenient for them. Prior to joining the Scripps Research Translational Institute, Dr. Vogel created, proposed, fundraised for, and implemented research and clinical genomics initiatives at the New York Genome Center and The Rockefeller University. She oversaw the proposal and execution of grants, including a $44M NIH Center for Common Disease Genomics in collaboration with over 20 scientific contributors across seven institutions. She also managed corporate partnerships, including one with IBM that assessed the relative value of several genomic assays for cancer patients. Dr. Vogel has a BS in Mathematics from Rensselaer Polytechnic Institute, a PhD in Computational Biology and Medicine from Cornell and an MBA from Cornell. Important Episode Links - Nature Reviews Microbiology - Long COVID: major findings, mechanisms and recommendations -https://www.nature.com/articles/s41579-022-00846-2npj Digital Medicine - Long-term changes in wearable sensor data in people with and without Long Covid -https://www.nature.com/articles/s41746-024-01238-xMayo Clinic Proceedings: Innovations, Quality & Outcomes - A Randomized Trial of At-Home COVID-19 Tests, Telemedicine, and Rapid Prescription Delivery for Immunocompromised Individuals -https://www.sciencedirect.com/science/article/pii/S2542454825000384#JuliaMooreVogel #ScrippsResearchInstitute #EricTopol #LongCovidTreatmentTrial #AllOfUsResearchProgram #ComputationalBiology #NewYorkGenomeCenter #MyalgicEncephalomyelitis #ChronicFatigueSyndrome #ImmuneDysregulation #MicrovascularInjury #MetabolicDysfunction #Neuroinflammation #AutonomicDysfunction #Tirzepatide #Zepbound #RemoteClinicalTrial #Cornell #RockefellerUniversity#MemorialSloanKetteringCancerCenter #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting #ViralPodcast #STEM #Innovation #Science #Technology #ResearchSupport the show
In this episode of BioTalk with Rich Bendis, Harry Coker, Jr., Secretary of the Maryland Department of Commerce, joins the podcast to discuss Maryland's rising momentum as a global biohealth and technology leader. Secretary Coker shares his unique journey from the CIA, NSA, and White House to leading Maryland's economic development strategy, highlighting the state's strengths in life sciences, its appeal to global investors, and the importance of public-private partnerships in accelerating innovation. Topics include Maryland's recent recognition as a Top 3 biopharma hub, the decision to prioritize Life Sciences and Computational Biology as “Lifehouse” sectors, and how the state is leveraging the BioHealth Capital Region identity to unite and expand its regional leadership. He also outlines Maryland's case for investment and why collaboration will be central to "Winning the Decade." Editing and post-production work for this episode was provided by The Podcast Consultant. The Honorable Harry Coker, Jr. was appointed by Governor Wes Moore as Maryland's Secretary of Commerce in 2025. He is a retired senior executive from the CIA and NSA, former National Cyber Director at the White House, and a career Naval Officer. Coker's leadership is shaped by decades of public service at the highest levels of national security and technology. At the Maryland Department of Commerce, he leads efforts to build an equitable, competitive economy centered around innovation, inclusion, and impact.
mRNA vaccines are not supposed to contain DNA. But Dr. Jessica Rose says a new study tested “32 vials of Pfizer and Moderna COVID products that included 16 unique lots… We did not only find DNA, we found it in ALL lots tested and most importantly, the DNA levels were all above pre-designated EMA thresholds of 10 ng/dose.” “We measured the amount of DNA in the vials using 2 methods… (qPCR and fluorometry),” she continues. “It was submitted as evidence on the congressional record by the honorable Senator Ron Johnson.” JP Sears is a comedian, author, and YouTuber known for his satirical take on politics, fitness, and faith. He hosts Awaken with JP on Rumble and YouTube. Follow at https://x.com/AwakenWithJP Dr. Jessica Rose is a Canadian researcher with a Bachelor's in Applied Mathematics and a Master's in Immunology from Memorial University of Newfoundland. She holds a PhD in Computational Biology from Bar Ilan University and completed postdoctoral research in Molecular Biology and Biochemistry. Find her at https://jessicasuniverse.com and follow at https://x.com/JesslovesMJK 「 SUPPORT OUR SPONSORS 」 Find out more about the brands that make this show possible and get special discounts on Dr. Drew's favorite products at https://drdrew.com/sponsors • FATTY15 – The future of essential fatty acids is here! Strengthen your cells against age-related breakdown with Fatty15. Get 15% off a 90-day Starter Kit Subscription at https://drdrew.com/fatty15 • PALEOVALLEY - "Paleovalley has a wide variety of extraordinary products that are both healthful and delicious,” says Dr. Drew. "I am a huge fan of this brand and know you'll love it too!” Get 15% off your first order at https://drdrew.com/paleovalley • VSHREDMD – Formulated by Dr. Drew: The Science of Cellular Health + World-Class Training Programs, Premium Content, and 1-1 Training with Certified V Shred Coaches! More at https://drdrew.com/vshredmd • THE WELLNESS COMPANY - Counteract harmful spike proteins with TWC's Signature Series Spike Support Formula containing nattokinase and selenium. Learn more about TWC's supplements at https://twc.health/drew 「 MEDICAL NOTE 」 Portions of this program may examine countervailing views on important medical issues. Always consult your physician before making any decisions about your health. 「 ABOUT THE SHOW 」 Ask Dr. Drew is produced by Kaleb Nation (https://kalebnation.com) and Susan Pinsky (https://twitter.com/firstladyoflove). This show is for entertainment and/or informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment. Learn more about your ad choices. Visit megaphone.fm/adchoices
In this episode of Data in Biotech, host Ross Katz talks with Jesper Ryge, Director of Computational Biology at Merck Germany. Jesper shares his journey from neuroscience labs to leading computational teams, offering deep insights into disease modeling, target discovery, and multi-omics integration. Discover how AI and spatial transcriptomics are shaping the future of pharma R&D. What You'll Learn in This Episode >> How single-cell and spatial transcriptomics enhance disease mechanism discovery >> Why data integration and knowledge graphs are critical for target validation >> How computational biology teams interface with wet lab research >> What makes Merck Germany's data strategy unique in biotech >> How generative AI is changing how pharma interprets complex datasets Meet Our Guest Jesper Ryge is Director of Computational Biology at Merck Germany. A biophysicist by training, he brings deep expertise in neuroscience, single-cell analysis, and bioinformatics to pharmaceutical R&D. About The Host Ross Katz is Principal and Data Science Lead at CorrDyn. Ross specializes in building intelligent data systems that empower biotech and healthcare organizations to extract insights and drive innovation. Connect with Our Guest: Sponsor: CorrDyn, a data consultancyFind out more about MerckConnect with Jesper Ryge on LinkedIn Connect with Us: Follow the podcast for more insightful discussions on the latest in biotech and data science.Subscribe and leave a review if you enjoyed this episode!Connect with Ross Katz on LinkedIn Sponsored by… This episode is brought to you by CorrDyn, the leader in data-driven solutions for biotech and healthcare. Discover how CorrDyn is helping organizations turn data into breakthroughs at CorrDyn.
What is the origin of life in the universe? Neil deGrasse Tyson and Matt Kirshen explore how life got its start, the Miller-Urey experiment, and synthetic biology with molecular biologist Kerstin Göpfrich. Could the first alien life we find be the one we make? NOTE: StarTalk+ Patrons can listen to this entire episode commercial-free here: https://startalkmedia.com/show/building-life-from-scratch-with-kerstin-gopfrich/Thanks to our Patrons Kory Thompson, Scott Brooks, Evelyn ZB, Ken Robertson, Richard Iserman, JenFran, Adam Peters, roccie hill, Linux Diner, Steve Jaeger, Devona Johnson, Aaron Cortese, Jennifer Hoying, Brian Howard, kuwar Ahluwalia, Tal Kennedy, Amanda Echon, Michael McCarron, George Katsoufis, Martin BElan, sebby randazzo, Doug, Eval, Nate Amsden, Preston Kersey, Brian, Larbi, Aaron N., Ericka Nightshade, Alisha Okoroafo, karla, Daniel Mekonnen, James J.C. Kelly, MM, Josue Montanez, Stephen Addy, Fox Riley, Caleb Lillard, Louis-Gabriel Thibault, Wendy Kleeb, Jakob Linderoth, Aura, Mary, Mike D'Agostino, Julia Donehew, Jorge, Daniel Tersigni, Lindsay M., Jay Dakota Nance, and Goose for supporting us this week. Subscribe to SiriusXM Podcasts+ to listen to new episodes of StarTalk Radio ad-free and a whole week early.Start a free trial now on Apple Podcasts or by visiting siriusxm.com/podcastsplus.
What is life? What is intelligence? What is… complexity? Neil deGrasse Tyson, Chuck Nice, and Gary O'Reilly learn how complexity science, chaos theory, and emergence help us understand our place in the universe with David Krakauer, president of the Santa Fe Institute.NOTE: StarTalk+ Patrons can listen to this entire episode commercial-free here:https://startalkmedia.com/show/emergence-explained-with-david-krakauer/Thanks to our Patrons teonie, Dixie Gamoning, Greg Meyer, Mike Bilodeau, Mitchell Keesler, john hutt, Karen Buss, The Merry Widow, Casandra Martin, Swaraj Jaiswal, Hoang Nguyen, Knooble Gooble, Panainte Victor, Peter Jensen, Rajesh Bhaidasna, Victor Pomales, George Mulder, Life Space and the Lot, RandomBrian423, blitzgrub, Travis Bridges, Sreya Kumpatla, Erik Scheirer, Natalie Tabor, SwaZam!, KILOCREAMYY, Lisa Peldiak, Tosin Awofeso, Joe Buzz, daevon pearson, Amie Christy, Simone Adair, Philippe, Logan Davis, Ted Parsons, Macs Ton, Ben, Quentin Ferguson, Ash De Zylva, Evalena Marie, Nancy Bijok, Jacob Garcia, The Preschool Doctor, Amber Shaw, Erin, ilya, Kevin Nguyen, Austin Weets, and Alan G for supporting us this week. Subscribe to SiriusXM Podcasts+ to listen to new episodes of StarTalk Radio ad-free and a whole week early.Start a free trial now on Apple Podcasts or by visiting siriusxm.com/podcastsplus.
When we think of the forces driving cancer, we don't necessarily think of evolution. But evolution and cancer are closely linked because the historical processes that created life also created cancer. The Cheating Cell: How Evolution Helps Us Understand and Treat Cancer (Princeton UP, 2020) delves into this extraordinary relationship, and shows that by understanding cancer's evolutionary origins, researchers can come up with more effective, revolutionary treatments. Athena Aktipis goes back billions of years to explore when unicellular forms became multicellular organisms. Within these bodies of cooperating cells, cheating ones arose, overusing resources and replicating out of control, giving rise to cancer. Aktipis illustrates how evolution has paved the way for cancer's ubiquity, and why it will exist as long as multicellular life does. Even so, she argues, this doesn't mean we should give up on treating cancer—in fact, evolutionary approaches offer new and promising options for the disease's prevention and treatments that aim at long-term management rather than simple eradication. Looking across species—from sponges and cacti to dogs and elephants—we are discovering new mechanisms of tumor suppression and the many ways that multicellular life-forms have evolved to keep cancer under control. By accepting that cancer is a part of our biological past, present, and future—and that we cannot win a war against evolution—treatments can become smarter, more strategic, and more humane. Unifying the latest research from biology, ecology, medicine, and social science, The Cheating Cell challenges us to rethink cancer's fundamental nature and our relationship to it. Hussein Mohsen is a PhD/MA Candidate in Computational Biology and Bioinformatics/History of Science and Medicine at Yale University. His research interests include machine learning, cancer genomics, and the history of human genetics. For more about his work, visit http://www.husseinmohsen.com. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network
When we think of the forces driving cancer, we don't necessarily think of evolution. But evolution and cancer are closely linked because the historical processes that created life also created cancer. The Cheating Cell: How Evolution Helps Us Understand and Treat Cancer (Princeton UP, 2020) delves into this extraordinary relationship, and shows that by understanding cancer's evolutionary origins, researchers can come up with more effective, revolutionary treatments. Athena Aktipis goes back billions of years to explore when unicellular forms became multicellular organisms. Within these bodies of cooperating cells, cheating ones arose, overusing resources and replicating out of control, giving rise to cancer. Aktipis illustrates how evolution has paved the way for cancer's ubiquity, and why it will exist as long as multicellular life does. Even so, she argues, this doesn't mean we should give up on treating cancer—in fact, evolutionary approaches offer new and promising options for the disease's prevention and treatments that aim at long-term management rather than simple eradication. Looking across species—from sponges and cacti to dogs and elephants—we are discovering new mechanisms of tumor suppression and the many ways that multicellular life-forms have evolved to keep cancer under control. By accepting that cancer is a part of our biological past, present, and future—and that we cannot win a war against evolution—treatments can become smarter, more strategic, and more humane. Unifying the latest research from biology, ecology, medicine, and social science, The Cheating Cell challenges us to rethink cancer's fundamental nature and our relationship to it. Hussein Mohsen is a PhD/MA Candidate in Computational Biology and Bioinformatics/History of Science and Medicine at Yale University. His research interests include machine learning, cancer genomics, and the history of human genetics. For more about his work, visit http://www.husseinmohsen.com. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/medicine
When we think of the forces driving cancer, we don't necessarily think of evolution. But evolution and cancer are closely linked because the historical processes that created life also created cancer. The Cheating Cell: How Evolution Helps Us Understand and Treat Cancer (Princeton UP, 2020) delves into this extraordinary relationship, and shows that by understanding cancer's evolutionary origins, researchers can come up with more effective, revolutionary treatments. Athena Aktipis goes back billions of years to explore when unicellular forms became multicellular organisms. Within these bodies of cooperating cells, cheating ones arose, overusing resources and replicating out of control, giving rise to cancer. Aktipis illustrates how evolution has paved the way for cancer's ubiquity, and why it will exist as long as multicellular life does. Even so, she argues, this doesn't mean we should give up on treating cancer—in fact, evolutionary approaches offer new and promising options for the disease's prevention and treatments that aim at long-term management rather than simple eradication. Looking across species—from sponges and cacti to dogs and elephants—we are discovering new mechanisms of tumor suppression and the many ways that multicellular life-forms have evolved to keep cancer under control. By accepting that cancer is a part of our biological past, present, and future—and that we cannot win a war against evolution—treatments can become smarter, more strategic, and more humane. Unifying the latest research from biology, ecology, medicine, and social science, The Cheating Cell challenges us to rethink cancer's fundamental nature and our relationship to it. Hussein Mohsen is a PhD/MA Candidate in Computational Biology and Bioinformatics/History of Science and Medicine at Yale University. His research interests include machine learning, cancer genomics, and the history of human genetics. For more about his work, visit http://www.husseinmohsen.com. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/science
When we think of the forces driving cancer, we don't necessarily think of evolution. But evolution and cancer are closely linked because the historical processes that created life also created cancer. The Cheating Cell: How Evolution Helps Us Understand and Treat Cancer (Princeton UP, 2020) delves into this extraordinary relationship, and shows that by understanding cancer's evolutionary origins, researchers can come up with more effective, revolutionary treatments. Athena Aktipis goes back billions of years to explore when unicellular forms became multicellular organisms. Within these bodies of cooperating cells, cheating ones arose, overusing resources and replicating out of control, giving rise to cancer. Aktipis illustrates how evolution has paved the way for cancer's ubiquity, and why it will exist as long as multicellular life does. Even so, she argues, this doesn't mean we should give up on treating cancer—in fact, evolutionary approaches offer new and promising options for the disease's prevention and treatments that aim at long-term management rather than simple eradication. Looking across species—from sponges and cacti to dogs and elephants—we are discovering new mechanisms of tumor suppression and the many ways that multicellular life-forms have evolved to keep cancer under control. By accepting that cancer is a part of our biological past, present, and future—and that we cannot win a war against evolution—treatments can become smarter, more strategic, and more humane. Unifying the latest research from biology, ecology, medicine, and social science, The Cheating Cell challenges us to rethink cancer's fundamental nature and our relationship to it. Hussein Mohsen is a PhD/MA Candidate in Computational Biology and Bioinformatics/History of Science and Medicine at Yale University. His research interests include machine learning, cancer genomics, and the history of human genetics. For more about his work, visit http://www.husseinmohsen.com.
When we think of the forces driving cancer, we don't necessarily think of evolution. But evolution and cancer are closely linked because the historical processes that created life also created cancer. The Cheating Cell: How Evolution Helps Us Understand and Treat Cancer (Princeton UP, 2020) delves into this extraordinary relationship, and shows that by understanding cancer's evolutionary origins, researchers can come up with more effective, revolutionary treatments. Athena Aktipis goes back billions of years to explore when unicellular forms became multicellular organisms. Within these bodies of cooperating cells, cheating ones arose, overusing resources and replicating out of control, giving rise to cancer. Aktipis illustrates how evolution has paved the way for cancer's ubiquity, and why it will exist as long as multicellular life does. Even so, she argues, this doesn't mean we should give up on treating cancer—in fact, evolutionary approaches offer new and promising options for the disease's prevention and treatments that aim at long-term management rather than simple eradication. Looking across species—from sponges and cacti to dogs and elephants—we are discovering new mechanisms of tumor suppression and the many ways that multicellular life-forms have evolved to keep cancer under control. By accepting that cancer is a part of our biological past, present, and future—and that we cannot win a war against evolution—treatments can become smarter, more strategic, and more humane. Unifying the latest research from biology, ecology, medicine, and social science, The Cheating Cell challenges us to rethink cancer's fundamental nature and our relationship to it. Hussein Mohsen is a PhD/MA Candidate in Computational Biology and Bioinformatics/History of Science and Medicine at Yale University. His research interests include machine learning, cancer genomics, and the history of human genetics. For more about his work, visit http://www.husseinmohsen.com. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/science-technology-and-society
When we think of the forces driving cancer, we don't necessarily think of evolution. But evolution and cancer are closely linked because the historical processes that created life also created cancer. The Cheating Cell: How Evolution Helps Us Understand and Treat Cancer (Princeton UP, 2020) delves into this extraordinary relationship, and shows that by understanding cancer's evolutionary origins, researchers can come up with more effective, revolutionary treatments. Athena Aktipis goes back billions of years to explore when unicellular forms became multicellular organisms. Within these bodies of cooperating cells, cheating ones arose, overusing resources and replicating out of control, giving rise to cancer. Aktipis illustrates how evolution has paved the way for cancer's ubiquity, and why it will exist as long as multicellular life does. Even so, she argues, this doesn't mean we should give up on treating cancer—in fact, evolutionary approaches offer new and promising options for the disease's prevention and treatments that aim at long-term management rather than simple eradication. Looking across species—from sponges and cacti to dogs and elephants—we are discovering new mechanisms of tumor suppression and the many ways that multicellular life-forms have evolved to keep cancer under control. By accepting that cancer is a part of our biological past, present, and future—and that we cannot win a war against evolution—treatments can become smarter, more strategic, and more humane. Unifying the latest research from biology, ecology, medicine, and social science, The Cheating Cell challenges us to rethink cancer's fundamental nature and our relationship to it. Hussein Mohsen is a PhD/MA Candidate in Computational Biology and Bioinformatics/History of Science and Medicine at Yale University. His research interests include machine learning, cancer genomics, and the history of human genetics. For more about his work, visit http://www.husseinmohsen.com. Learn more about your ad choices. Visit megaphone.fm/adchoices
Dr. Jessica Rose is an artist, musician, mathematician, professional surfer, biologist, science researcher & data analysis. Dr. Rose has a Post Doc in Biochemistry at Technion Institute of Technology, Post Doc in Molecular Biology at Hebrew University of Jerusalem, PhD in Computational Biology at Bar-Ilan University, Master's in Medicine (Immunology) at Memorial University of Newfoundland, and BSc in Applied Mathematics at Memorial University of Newfoundland.DR. JESSICA ROSE:Twitter: https://twitter.com/JesslovesMJKSubStack: https://jessicar.substack.com/YouTube: https://www.youtube.com/channel/UC0EhWf2Vswdg7DwKKKZ34ngTHE RIPPLE EFFECT PODCAST:WEBSITE: http://TheRippleEffectPodcast.comWebsite Host & Video Distributor: https://ContentSafe.co/SUPPORT:PATREON: https://www.patreon.com/TheRippleEffectPodcastPayPal: https://www.PayPal.com/paypalme/RvTheory6VENMO: https://venmo.com/code?user_id=3625073915201071418&created=1663262894MERCH Store: http://www.TheRippleEffectPodcastMerch.comMUSIC: https://music.apple.com/us/album/the-ripple-effect-ep/1057436436SPONSORS:OPUS A.I. Clip Creator: https://www.opus.pro/?via=RickyVarandasUniversity of Reason-Autonomy: https://www.universityofreason.com/a/2147825829/ouiRXFoL WATCH:RUMBLE: https://rumble.com/c/therippleeffectpodcastBANNED.VIDEO: https://banned.video/channel/the-ripple-effect-podcastOFFICIAL YOUTUBE: https://www.youtube.com/@TheRippleEffectPodcastOFFICIALYOUTUBE CLIPS CHANNEL: https://www.youtube.com/@RickyVarandasTikTok: https://www.tiktok.com/@ricky.varandasLISTEN:SPOTIFY: https://open.spotify.com/show/4lpFhHI6CqdZKW0QDyOicJiTUNES: http://apple.co/1xjWmlFPodOmatic: https://www.podomatic.com/podcasts/rvtheory6CONNECT:TeleGram: https://t.me/TREpodcastX: https://x.com/RvTheory6IG: https://www.instagram.com/rvtheory6/ FB: https://www.facebook.com/TheRippleEffectPodcast/THE UNION OF THE UNWANTED: https://linktr.ee/TheUnionOfTheUnwanted
Dr. Jessica Rose is an artist, musician, mathematician, professional surfer, biologist, science researcher & data analysis. Dr. Rose has a Post Doc in Biochemistry at Technion Institute of Technology, Post Doc in Molecular Biology at Hebrew University of Jerusalem, PhD in Computational Biology at Bar-Ilan University, Master's in Medicine (Immunology) at Memorial University of Newfoundland, and BSc in Applied Mathematics at Memorial University of Newfoundland.DR. JESSICA ROSE:Twitter: https://twitter.com/JesslovesMJKSubStack: https://jessicar.substack.com/YouTube: https://www.youtube.com/channel/UC0EhWf2Vswdg7DwKKKZ34ngTHE RIPPLE EFFECT PODCAST:WEBSITE: http://TheRippleEffectPodcast.comWebsite Host & Video Distributor: https://ContentSafe.co/SUPPORT:PATREON: https://www.patreon.com/TheRippleEffectPodcastPayPal: https://www.PayPal.com/paypalme/RvTheory6VENMO: https://venmo.com/code?user_id=3625073915201071418&created=1663262894MERCH Store: http://www.TheRippleEffectPodcastMerch.comMUSIC: https://music.apple.com/us/album/the-ripple-effect-ep/1057436436SPONSORS:OPUS A.I. Clip Creator: https://www.opus.pro/?via=RickyVarandasUniversity of Reason-Autonomy: https://www.universityofreason.com/a/2147825829/ouiRXFoL WATCH:RUMBLE: https://rumble.com/c/therippleeffectpodcastBANNED.VIDEO: https://banned.video/channel/the-ripple-effect-podcastOFFICIAL YOUTUBE: https://www.youtube.com/@TheRippleEffectPodcastOFFICIALYOUTUBE CLIPS CHANNEL: https://www.youtube.com/@RickyVarandasTikTok: https://www.tiktok.com/@ricky.varandasLISTEN:SPOTIFY: https://open.spotify.com/show/4lpFhHI6CqdZKW0QDyOicJiTUNES: http://apple.co/1xjWmlFPodOmatic: https://www.podomatic.com/podcasts/rvtheory6CONNECT:TeleGram: https://t.me/TREpodcastX: https://x.com/RvTheory6IG: https://www.instagram.com/rvtheory6/ FB: https://www.facebook.com/TheRippleEffectPodcast/THE UNION OF THE UNWANTED: https://linktr.ee/TheUnionOfTheUnwanted
Featuring Dave Beverley Sr (Jesus Freak Computer Geek), Pete Ohlinger (Days of Noah Podcast), & Dr. Alphonzo Monzo (DrMonzo.com)Join host Rod Smith on the Millennial Mustard Seed Podcast for a riveting exploration into how cutting-edge science and technology intersect with the spiritual realm. In this episode, our distinguished panel dives into the transformative worlds of CRISPR gene editing, Computational Bio, Energy Harvesting Beast Tech, W-Band, and self healing nephilim nano tech are just a few of the wild discussion points on this part two roundtable episode. share this one far and wide friends!Explore the possibility that modern science and technology are playing an unforeseen role in the cosmic battle between light and darkness.• Panel Perspectives: Hear from Dave Beverley Sr, Pete Ohlinger, and Dr. Alphonzo Monzo as they blend scientific insight with a biblical lens, challenging conventional narratives and inspiring deeper faith in Christ.• Plant a seed in time of need: https://creators.spotify.com/pod/show/rodney-jay/subscribe• Email Rod Smith:mmseed@proton.me Partner with Our Ministry: Consider supporting and partnering with us as we spread the Gospel through innovative media.• Buy a Copy of My New Book! https://a.co/d/3Gf5sqK• Venmo:@Rodney-Smith-368• PayPal:@creative775• Cash App:$Rodsworth77
Dr. Jessica Rose is an artist, musician, mathematician, professional surfer, biologist, science researcher & data analysis. Dr. Rose has a Post Doc in Biochemistry at Technion Institute of Technology, Post Doc in Molecular Biology at Hebrew University of Jerusalem, PhD in Computational Biology at Bar-Ilan University, Master's in Medicine (Immunology) at Memorial University of Newfoundland, and BSc in Applied Mathematics at Memorial University of Newfoundland.DR. JESSICA ROSE:Twitter: https://twitter.com/JesslovesMJKSubStack: https://jessicar.substack.com/YouTube: https://www.youtube.com/channel/UC0EhWf2Vswdg7DwKKKZ34ngTHE RIPPLE EFFECT PODCAST:WEBSITE: http://TheRippleEffectPodcast.comWebsite Host & Video Distributor: https://ContentSafe.co/SUPPORT:PATREON: https://www.patreon.com/TheRippleEffectPodcastPayPal: https://www.PayPal.com/paypalme/RvTheory6VENMO: https://venmo.com/code?user_id=3625073915201071418&created=1663262894MERCH Store: http://www.TheRippleEffectPodcastMerch.comMUSIC: https://music.apple.com/us/album/the-ripple-effect-ep/1057436436SPONSORS:OPUS A.I. Clip Creator: https://www.opus.pro/?via=RickyVarandasUniversity of Reason-Autonomy: https://www.universityofreason.com/a/2147825829/ouiRXFoL WATCH:RUMBLE: https://rumble.com/c/therippleeffectpodcastBANNED.VIDEO: https://banned.video/channel/the-ripple-effect-podcastOFFICIAL YOUTUBE: https://www.youtube.com/@TheRippleEffectPodcastOFFICIALYOUTUBE CLIPS CHANNEL: https://www.youtube.com/@RickyVarandasTikTok: https://www.tiktok.com/@ricky.varandasLISTEN:SPOTIFY: https://open.spotify.com/show/4lpFhHI6CqdZKW0QDyOicJiTUNES: http://apple.co/1xjWmlFPodOmatic: https://www.podomatic.com/podcasts/rvtheory6CONNECT:TeleGram: https://t.me/TREpodcastX: https://x.com/RvTheory6IG: https://www.instagram.com/rvtheory6/ FB: https://www.facebook.com/TheRippleEffectPodcast/THE UNION OF THE UNWANTED: https://linktr.ee/TheUnionOfTheUnwanted
In this episode of Crazy Wisdom, Stewart Alsop speaks with German Jurado about the strange loop between computation and biology, the emergence of reasoning in AI models, and what it means to "stand on the shoulders" of evolutionary systems. They talk about CRISPR not just as a gene-editing tool, but as a memory architecture encoded in bacterial immunity; they question whether LLMs are reasoning or just mimicking it; and they explore how scientists navigate the unknown with a kind of embodied intuition. For more about German's work, you can connect with him through email at germanjurado7@gmail.com.Check out this GPT we trained on the conversation!Timestamps00:00 - Stewart introduces German Jurado and opens with a reflection on how biology intersects with multiple disciplines—physics, chemistry, computation.05:00 - They explore the nature of life's interaction with matter, touching on how biology is about the interface between organic systems and the material world.10:00 - German explains how bioinformatics emerged to handle the complexity of modern biology, especially in genomics, and how it spans structural biology, systems biology, and more.15:00 - Introduction of AI into the scientific process—how models are being used in drug discovery and to represent biological processes with increasing fidelity.20:00 - Stewart and German talk about using LLMs like GPT to read and interpret dense scientific literature, changing the pace and style of research.25:00 - The conversation turns to societal implications—how these tools might influence institutions, and the decentralization of expertise.30:00 - Competitive dynamics between AI labs, the scaling of context windows, and speculation on where the frontier is heading.35:00 - Stewart reflects on English as the dominant language of science and the implications for access and translation of knowledge.40:00 - Historical thread: they discuss the Republic of Letters, how the structure of knowledge-sharing has evolved, and what AI might do to that structure.45:00 - Wrap-up thoughts on reasoning, intuition, and the idea of scientists as co-evolving participants in both natural and artificial systems.50:00 - Final reflections and thank-yous, German shares where to find more of his thinking, and Stewart closes the loop on the conversation.Key InsightsCRISPR as a memory system – Rather than viewing CRISPR solely as a gene-editing tool, German Jurado frames it as a memory architecture—an evolved mechanism through which bacteria store fragments of viral DNA as a kind of immune memory. This perspective shifts CRISPR into a broader conceptual space, where memory is not just cognitive but deeply biological.AI models as pattern recognizers, not yet reasoners – While large language models can mimic reasoning impressively, Jurado suggests they primarily excel at statistical pattern matching. The distinction between reasoning and simulation becomes central, raising the question: are these systems truly thinking, or just very good at appearing to?The loop between computation and biology – One of the core themes is the strange feedback loop where biology inspires computational models (like neural networks), and those models in turn are used to probe and understand biological systems. It's a recursive relationship that's accelerating scientific insight but also complicating our definitions of intelligence and understanding.Scientific discovery as embodied and intuitive – Jurado highlights that real science often begins in the gut, in a kind of embodied intuition before it becomes formalized. This challenges the myth of science as purely rational or step-by-step and instead suggests that hunches, sensory experience, and emotional resonance play a crucial role.Proteins as computational objects – Proteins aren't just biochemical entities—they're shaped by information. Their structure, function, and folding dynamics can be seen as computations, and tools like AlphaFold are beginning to unpack that informational complexity in ways that blur the line between physics and code.Human alignment is messier than AI alignment – While AI alignment gets a lot of attention, Jurado points out that human alignment—between scientists, institutions, and across cultures—is historically chaotic. This reframes the AI alignment debate in a broader evolutionary and historical context, questioning whether we're holding machines to stricter standards than ourselves.Standing on the shoulders of evolutionary processes – Evolution is not just a backdrop but an active epistemic force. Jurado sees scientists as participants in a much older system of experimentation and iteration—evolution itself. In this view, we're not just designing models; we're being shaped by them, in a co-evolution of tools and understanding.
In this episode, we explore how a generative AI tool is marking a major milestone in biology and accelerating advancements in healthcare, genetics, and drug development. Become a founding reader of our newsletter: http://read.thenextbyte.com/ As always, you can find these and other interesting & impactful engineering articles on Wevolver.com.
It could be argued that biology has always boiled down to chemistry, and that chemistry has always boiled down to physics. However, not many would deny that the fields of biology and chemistry are overlapping more than ever, with both leveraging computing methods, also more than ever. This conversation with Dr. Ramesh Jha, Technical Staff Member at Los Alamos National Laboratory (LANL), crosses biology, chemistry, and computing methods. The work of his biome team at LANL uses computational tools to inform the design of enzymes that are produced via PCR-based cloning and then expressed in microbes. They use fluorescent gene circuits in these microbes, along with flow cytometry, to screen these large libraries for advantageous gain-of-function variants. When they find an interesting mutation, they isolate it, sequence it, and produce and evaluate those biocatalytic enzymes for bioremediation, biomanufacturing, and other important applications. Ramesh makes this complex and interdisciplinary science approachable and gives hope to how it could help address problems of “forever chemicals” and other environmental and manufacturing challenges. Join us for this interesting and inspiring conversation. Subscribe to get future episodes as they drop and if you like what you're hearing we hope you'll share a review or recommend the series to a colleague. Visit the Invitrogen School of Molecular Biology to access helpful molecular biology resources and educational content, and please share this resource with anyone you know working in molecular biology. For Research Use Only. Not for use in diagnostic procedures.
(2:30) - AI-designed proteins neutralise snake toxinsThis episode was brought to you by Mouser, our favorite place to get electronics parts for any project, whether it be a hobby at home or a prototype for work. Click HERE to learn more about how AI is being used to expedite the drug development discovery phase! Hint: it's a great primer for this episode :) Become a founding reader of our newsletter: http://read.thenextbyte.com/ As always, you can find these and other interesting & impactful engineering articles on Wevolver.com.
In this thought-provoking episode, we sit down with Dr. Jessica Rose, a highly credentialed independent researcher, to examine the inconsistencies in vaccine safety data, mRNA concerns, and the role of pharmacovigilance. With a background spanning Applied Mathematics, Immunology, Computational Biology, and Molecular Biochemistry, Dr. Rose has been rigorously analyzing VAERS data since the COVID-19 vaccine rollout—uncovering critical insights into public health policies and their impact on society. Tune in to explore: How Dr. Rose's expertise in science and mathematics challenged mainstream COVID narratives. The function of pharmacovigilance databases in tracking vaccine-related injuries. Major discrepancies in public health data—and why they matter. A data-driven comparison between the 2019 flu vaccine and COVID-19 vaccine reports. With vaccine safety at the forefront of medical discussions, what will it take to ensure transparency in public health reporting? Listen in now to find out! You can stay updated on Dr. Rose's latest findings on Substack and X and also and check out her newly published research paper here. Episode also available on Apple Podcasts: https://apple.co/38oMlMr
In this episode, we delve into the complex topic of vaccine safety and DNA contamination with Dr. Jessica Rose, an independent researcher with a BSc in Applied Mathematics, an MSc in Immunology, a Ph.D. in Computational Biology, and two postdoctoral fellowships in Molecular Biology and Biochemistry. Since the start of the COVID-19 vaccine rollout, Dr. Rose has been meticulously analyzing VAERS data on adverse reactions. Her mission? To uncover the truth behind past and present health policies through rigorous, data-driven research… Hit play to learn about: How Dr. Rose's understanding of mathematics and science came into conflict during the COVID narrative. The purpose of pharmacovigilance databases. The many “scams” that took place throughout the pandemic. What happened when Dr. Rose compared the 2019 influenza vaccine-related injuries with those of Coronavirus. What will it take to get to the bottom of the inaccuracies of public health data? How do incorrect reports impact the welfare of our society? Join the conversation now to see for yourself! You can follow along with Dr. Rose and her ongoing work on Substack and X. Boost Your Brainpower with 15% OFF! Fuel your mind with BrainSupreme Supplements and unlock your full potential. Get 15% OFF your order now using this exclusive link: brainsupreme.co/discount/findinggenius Hurry—your brain deserves the best! Episode also available on Apple Podcasts: http://apple.co/30PvU9C
We're experimenting and would love to hear from you!In this episode of 'Discover Daily', we delve into the groundbreaking advancements in AI-driven drug discovery, highlighting DeepMind's AlphaFold 3 and significant partnerships between Isomorphic Labs and pharmaceutical giants Eli Lilly and Novartis. The episode explores how these collaborations, backed by substantial investments reaching into billions, are revolutionizing the development of small molecule therapeutics and accelerating the traditionally lengthy drug development process.We then shift to Finland's historic entry into the Artemis Accords as the 53rd nation and first signatory of 2025, marking a significant milestone in international space cooperation. This strategic move not only demonstrates Finland's commitment to peaceful space exploration but also positions the country to benefit from potential investment returns and enhanced polar region monitoring capabilities in response to increasing climate change impacts.The episode concludes with a detailed examination of a new executive order mandating the declassification of remaining files related to the assassinations of JFK, RFK, and MLK Jr. This unprecedented move towards transparency sets specific timelines for intelligence agencies to develop comprehensive release plans, potentially unveiling new insights into these pivotal moments in American history while addressing decades of public interest in these historical events.From Perplexity's Discover Feed: https://www.perplexity.ai/page/ai-developed-drugs-coming-soon-KafDx1.USaWRvWfDBgYk.g https://www.perplexity.ai/page/finland-signs-artemis-accords-SJdroKJERvqYlwwVm9z_pQhttps://www.perplexity.ai/page/trump-signs-executive-order-to-rUYlBy8tR1yBhoZc8YhyCg Perplexity is the fastest and most powerful way to search the web. Perplexity crawls the web and curates the most relevant and up-to-date sources (from academic papers to Reddit threads) to create the perfect response to any question or topic you're interested in. Take the world's knowledge with you anywhere. Available on iOS and Android Join our growing Discord community for the latest updates and exclusive content. Follow us on: Instagram Threads X (Twitter) YouTube Linkedin
Dr. Jessica Rose is an artist, musician, mathematician, professional surfer, biologist, researcher, & data analysis. Dr. Rose has a Post Doc in Biochemistry at Technion Institute of Technology, Post Doc in Molecular Biology at Hebrew University of Jerusalem, PhD in Computational Biology at Bar-Ilan University, Master's in Medicine (Immunology) at Memorial University of Newfoundland, and BSc in Applied Mathematics at Memorial University of Newfoundland.DR. JESSICA ROSE:Twitter: https://twitter.com/JesslovesMJKSubStack: https://jessicar.substack.com/YouTube: https://www.youtube.com/channel/UC0EhWf2Vswdg7DwKKKZ34ngTHE RIPPLE EFFECT PODCAST:WEBSITE: http://TheRippleEffectPodcast.comWebsite Host & Video Distributor: https://ContentSafe.co/SUPPORT:PATREON: https://www.patreon.com/TheRippleEffectPodcastPayPal: https://www.PayPal.com/paypalme/RvTheory6VENMO: https://venmo.com/code?user_id=3625073915201071418&created=1663262894MERCH Store: http://www.TheRippleEffectPodcastMerch.comMUSIC: https://music.apple.com/us/album/the-ripple-effect-ep/1057436436Send BitCoin: bc1qh0w0xyud67gvexwenh9fszzqy0np799h9qffyqSend Ethereum: 0xfeda6Da1EE8Aa06E0d63272c886277153C1ef34dWATCH:RUMBLE: https://rumble.com/c/c-745495ROKFIN: https://rokfin.com/RippleEffectODYSEE: https://odysee.com/@therippleeffectpodcast:dBITCHUTE: https://www.bitchute.com/channel/6bOtjURD1rds/BANNED.VIDEO: https://banned.video/channel/the-ripple-effect-podcast YOUTUBE: https://www.youtube.com/channel/UCVfy9MXhb5EIciYRIO9cKUwLISTEN:SPOTIFY: https://open.spotify.com/show/4lpFhHI6CqdZKW0QDyOicJiTUNES: http://apple.co/1xjWmlFPodOmatic: https://www.podomatic.com/podcasts/rvtheory6CONNECT:TeleGram: https://t.me/TREpodcastX: https://x.com/RvTheory6IG: https://www.instagram.com/rvtheory6/FB: https://www.facebook.com/TheRippleEffectPodcast/THE UNION OF THE UNWANTED: https://linktr.ee/TheUnionOfTheUnwanted
This week, Jonathan is joined by Dr Shahram Kordasti, Associate Professor in Applied Cancer Immunopathology at King's College London, UK. In this episode, Dr Kordasti discusses the immunobiology of Myelodysplastic syndrome and Aplastic anaemia, the role of CD4+ T cells in myeloid malignancies, and how cutting-edge computational tools are enhancing treatment strategies. Timestamps: (00:00)-Introduction (01:23)-Hodgkin's lymphoma origin (04:21)- Immunobiology of diseases (08:55)-Plasticity of T cells (13:42)-Computational biology and multiomics for patient stratification (21:00)-Standardising immune monitoring (25:41)- Pretreatment with systemic agents (27:55)- Myeloproliferative neoplasms (31:48)-Synthetic data generation (36:22)-Exciting developments on the horizon (39:16)-Three wishes for healthcare
Dr. Jessica Rose is a musician, artist, surfer, Canadian researcher with a Bachelor's Degree in Applied Mathematics and a Master's degree in Immunology from Memorial University of Newfoundland. She also holds a PhD in Computational Biology and 2 Post Doctoral degrees: one in Molecular Biology and one in Biochemistry. She talks recovering from her recent hand injury, power of big pharma, work of Kevin McKernan, decentralization, what the next 4 years might look like and much more. PLEASE SUBSCRIBE LIKE AND SHARE THIS PODCAST!!! Video Version of Show Rumble- https://rumble.com/v5ztdpn-coffee-and-a-mike-dr.-jessica-rose-normalizing-the-platform.html YouTube- https://youtu.be/uNZcNxzh5LQ Follow Me Twitter/X- https://x.com/CoffeeandaMike IG- https://www.instagram.com/coffeeandamike/ Facebook- https://www.facebook.com/CoffeeandaMike/ YouTube- https://www.youtube.com/@Coffeeandamike Rumble- https://rumble.com/search/all?q=coffee%20and%20a%20mike Apple Podcasts- https://podcasts.apple.com/us/podcast/coffee-and-a-mike/id1436799008 Gab- https://gab.com/CoffeeandaMike Locals- https://coffeeandamike.locals.com/ Website- www.coffeeandamike.com Email- info@coffeeandamike.com Support My Work Venmo- https://www.venmo.com/u/coffeeandamike Paypal- https://www.paypal.com/biz/profile/Coffeeandamike Patreon- http://patreon.com/coffeeandamike Locals- https://coffeeandamike.locals.com/ Cash App- https://cash.app/$coffeeandamike Mail Check or Money Order- Coffee and a Mike LLC P.O. Box 25383 Scottsdale, AZ 85255-9998 Follow Jessica X- https://x.com/JesslovesMJK Website- https://www.jessicasuniverse.com/ Substack- https://substack.com/profile/40349025-jessica-rose Sponsors Vaulted/Precious Metals- https://vaulted.blbvux.net/coffeeandamike Independence Ark Natural Farming- https://www.independenceark.com/
The Defender reports “Arcturus Therapeutics announced earlier this week that the U.S. Food and Drug Administration (FDA) issued a “Study Can Proceed” notification for its investigational ARCT-2304 vaccine candidate.” Jessica Rose PhD says there are “major red flags.” The Defender also reported that “In clinical trials for the self-amplifying COVID-19 vaccine offered in Japan, “five deaths occurred among the injected in study phase 3b. Injected participants experienced a 90% adverse event rate (74.5% systemic, 15.2% required medical attention) after the first dose in study phases 1, 2, and 3a combined…” Dr. Clare Craig, BM BCh FRCPath, is a diagnostic pathologist, author, and co-chair of HART (Health Advisory and Recovery Team). She studied medicine at Cambridge and completed clinical training at Oxford. After 15 years in the NHS, she became pathology lead for the cancer arm of the 100,000 Genomes Project at Genomics England. She is the author of “Expired: Covid the Untold Story” and advocates for public education on COVID. Find more at https://hart.org and https://x.com/ClareCraigPath Dr. Jessica Rose is a Canadian researcher with a Bachelor's in Applied Mathematics and a Master's in Immunology from Memorial University of Newfoundland. She holds a PhD in Computational Biology from Bar Ilan University and completed postdoctoral research in Molecular Biology at the Hebrew University of Jerusalem and Biochemistry at the Technion Institute of Technology. Her recent work focuses on descriptive analysis of Vaccine Adverse Event Reporting System (VAERS) data. Find her at https://jessicasuniverse.com and https://jessicar.substack.com 「 SUPPORT OUR SPONSORS 」 Find out more about the brands that make this show possible and get special discounts on Dr. Drew's favorite products at https://drdrew.com/sponsors • CAPSADYN - Get pain relief with the power of capsaicin from chili peppers – without the burning! Capsadyn's proprietary formulation for joint & muscle pain contains no NSAIDs, opioids, anesthetics, or steroids. Try it for 15% off at https://drdrew.com/capsadyn • FATTY15 – The future of essential fatty acids is here! Strengthen your cells against age-related breakdown with Fatty15. Get 15% off a 90-day Starter Kit Subscription at https://drdrew.com/fatty15 • CHECK GENETICS - Your DNA is the key to discovering the RIGHT medication for you. Escape the big pharma cycle and understand your genetic medication blueprint with pharmacogenetic testing. Save $200 with code DRDREW at https://drdrew.com/check • PALEOVALLEY - "Paleovalley has a wide variety of extraordinary products that are both healthful and delicious,” says Dr. Drew. "I am a huge fan of this brand and know you'll love it too!” Get 15% off your first order at https://drdrew.com/paleovalley • THE WELLNESS COMPANY - Counteract harmful spike proteins with TWC's Signature Series Spike Support Formula containing nattokinase and selenium. Learn more about TWC's supplements at https://twc.health/drew 「 MEDICAL NOTE 」 Portions of this program may examine countervailing views on important medical issues. Always consult your physician before making any decisions about your health. 「 ABOUT THE SHOW 」 Ask Dr. Drew is produced by Kaleb Nation (https://kalebnation.com) and Susan Pinsky (https://twitter.com/firstladyoflove). This show is for entertainment and/or informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment. Learn more about your ad choices. Visit megaphone.fm/adchoices
What would you like to see more of? Let us know!In this episode of Discover Daily, we explore two major technological breakthroughs shaping our future. First, we discuss DeepMind's release of AlphaFold 3's source code, a significant advancement in protein structure prediction that promises to accelerate drug development by up to three years. With 76% accuracy in protein-ligand interactions and 65% accuracy in protein-DNA interactions, this open-source release marks a new era in computational biology and pharmaceutical research.We then delve into China's ambitious Solar Great Wall project, a massive renewable energy installation that stretches 400 kilometers across Inner Mongolia's desert landscape. This unprecedented initiative combines solar power generation with ecological restoration, featuring 196,000 solar panels in the Dalad Banner section alone. By 2030, the project aims to generate 180 billion kilowatt-hours annually, exceeding Beijing's current annual power consumption while simultaneously combating desertification.The dual-purpose design of the Solar Great Wall showcases how renewable energy projects can address multiple challenges simultaneously. Beyond power generation, the installation creates 50,000 new jobs, enables desert farming under the panels, and serves as a protective barrier for the Yellow River ecosystem. The project's innovative bifacial panels and AI-driven tracking systems demonstrate China's commitment to leading the global transition to sustainable energy.From Perplexity's Discover Feed:https://www.perplexity.ai/page/deepmind-releases-alphafold-co-jvNh2oy5TLyXE0SSrjYSCghttps://www.perplexity.ai/page/china-s-solar-great-wall-opa_xYm3RdO7j31AfESZuwPerplexity is the fastest and most powerful way to search the web. Perplexity crawls the web and curates the most relevant and up-to-date sources (from academic papers to Reddit threads) to create the perfect response to any question or topic you're interested in. Take the world's knowledge with you anywhere. Available on iOS and Android Join our growing Discord community for the latest updates and exclusive content. Follow us on: Instagram Threads X (Twitter) YouTube Linkedin
In this episode, we welcome Dr. Eric Fauman, Executive Director and Head of Computational Biology in the Internal Medicine Research Unit at Pfizer. Eric and Patrick discuss facilitating efficient identification of potential drug targets and the role of artificial intelligence in genetics research and drug discovery. Please note that Eric has kindly shared some interesting research that was mentioned in the podcast. It is pasted at the end of the show notes.
I am excited to connect with Dr. Nicola Sykes today. Dr. Sykes received her Ph.D. in Computational Biology from MIT. After experiencing hypothalamic amenorrhea and discovering a shortage of information about the condition in the public domain, she wrote a comprehensive guide to help people understand it and recover. In our discussion today, we dive into the nature of hypothalamic amenorrhea and explore its physiology. We address the effects of amenorrhea on eating habits, discuss caloric restrictions, fasting, exercise, and chronic stress, clarify the distinctions between eating disorders and disordered eating, and examine the role of genetics. Dr. Sykes also explains why she does not believe in post-pill amenorrhea, and our conversation touches on differentiators with polycystic ovarian syndrome, symptoms, and lab evaluations. Given the frequent concerns from listeners about losing their menstrual cycles, this conversation with Dr. Sykes promises to be particularly valuable for those affected by prolonged fasting and similar issues. IN THIS EPISODE YOU WILL LEARN: Dr. Sykes explains what hypothalamic amenorrhea is and why it is essential for women to understand it How a lack of exercise and energy deficits can impact menstruation Why we must support our bodies with exercise and proper nutrition rather than focusing on weight loss How stress impacts the body, particularly during perimenopause and menopause Why rest and recovery are essential when doing high-intensity workouts How we need to eat enjoyable foods and focus on moderation instead of striving for an ideal standard How disordered eating differs from eating disorders The difference between hypothalamic amenorrhea and PCOS Some common symptoms of hormone imbalance The benefits of tracking menstrual and ovulation cycles Bio: Dr Sykes (formerly Rinaldi) has a PhD in computational biology from MIT. After experiencing hypothalamic amenorrhea herself and finding a lack of information about the condition in the public sphere, she set out to write a comprehensive guide to understanding the condition and how to recover. Her book, "No Period. Now What?" has helped thousands of people recover from missing periods and better understand their bodies and hormonal systems. The book has been translated into multiple languages and serves as a guide for numerous dietitians and medical professionals helping those experiencing missing periods. Connect with Cynthia Thurlow Follow on Twitter Instagram LinkedIn Check out Cynthia's website Submit your questions to support@cynthiathurlow.com Connect with Dr. Nicola Sykes On her website Instagram Support group Buy ebook: No Period. Now what? Schedule a one-on-one session with Dr. Sykes
Rishi Khan is the President of Extreme Scale Solutions and the Chief Technology Officer at AKOS Solutions, companies that specialize in large-scale simulation, analysis, and leveraging AI and high-performance computing to solve complex challenges. With a PhD in Computational Biology, Rishi has spearheaded transformative AI projects in collaboration with industry leaders like DARPA and Qualcomm. His expertise spans workload analysis, hardware simulation, and advanced toolchain development, significantly impacting DOE and DoD operations. Rishi's active participation in the Entrepreneurs' Organization enhances his experience, providing valuable opportunities to connect with and learn from fellow business leaders. In this episode… Artificial Intelligence (AI) is a buzzword, but how much of it is hype versus hope? Revolutionizing productivity and scaling capabilities with AI has become a trending topic across industries. And the stories are as varied as they are incredible, but what's the real score? Rishi Khan addresses these challenges by emphasizing the importance of utilizing AI in diverse industries, from high-performance computing to practical business applications. He highlights the transformative impact of AI in tasks such as workload analysis, hardware simulation, and the development of advanced toolchains. Rishi's innovative approach includes pioneering Fourier Neural operators, which significantly enhance simulation speeds, demonstrating how AI can not only accelerate but also revolutionize various complex processes. Tune in to this episode of the Smart Business Revolution Podcast as John Corcoran interviews Rishi Khan, Chief Technology Officer at AKOS Solutions, about harnessing artificial intelligence in modern business and government operations. They also discussed the use of AI for optimizing business operations, guiding drilling and carbon sequestration decisions in the oil industry, and accelerating prospect research and improvement of lead generation strategies.
Dr. Jessica Rose is an artist, musician, mathematician, professional surfer, biologist, researcher, & data analysis. Dr. Rose has a Post Doc in Biochemistry at Technion Institute of Technology, Post Doc in Molecular Biology at Hebrew University of Jerusalem, PhD in Computational Biology at Bar Ilan University, Master's in Medicine (Immunology) at Memorial University of Newfoundland, and BSc in Applied Mathematics at Memorial University of Newfoundland.DR. JESSICA ROSEWebsite: https://www.jessicasuniverse.com/Twitter: https://twitter.com/JesslovesMJKSubStack: https://jessicar.substack.com/Monica Perez was a radio host for 8 1/2 years on WSB Radio in Atlanta; prior to that she was an investment banker in New York and Texas. From that previous life, Monica holds an associate's degree from Rockland Community College, a bachelor's degree from Harvard, and a JD-MBA from Stanford. She is a Chartered Financial Analyst as well as a member of the bar of the State of New York. Monica is also the host of The Monica Perez Show. MONICA PEREZ:WEBSITE: https://monicaperezshow.com/LinkTree: https://linktr.ee/monicaperezshowTHE RIPPLE EFFECT PODCAST:WEBSITE: http://TheRippleEffectPodcast.comSUPPORT:PATREON: https://www.patreon.com/TheRippleEffectPodcastPayPal: https://www.PayPal.com/paypalme/RvTheory6VENMO: https://venmo.com/code?user_id=3625073915201071418&created=1663262894Send BitCoin: bc1qh0w0xyud67gvexwenh9fszzqy0np799h9qffyqSend Ethereum: 0xfeda6Da1EE8Aa06E0d63272c886277153C1ef34dMERCH Store: http://www.TheRippleEffectPodcastMerch.comMUSIC: https://music.apple.com/us/album/the-ripple-effect-ep/1057436436SPONSORS:LMNT Electrolyte Drink Mix (Free Gift With Purchase): http://DrinkLMNT.com/TheRippleEffectTHE UNIVERSITY OF REASON (Autonomy Course): https://www.universityofreason.com/a/29887/ouiRXFoLBig Frog Custom T-Shirts & More (Website): https://www.bigfrog.com/beaverton/ContentSafe: https://ContentSafe.co/WATCH:RUMBLE: https://rumble.com/c/c-745495YOUTUBE: https://www.youtube.com/channel/UCVfy9MXhb5EIciYRIO9cKUwLISTEN:SPOTIFY: https://open.spotify.com/show/4lpFhHI6CqdZKW0QDyOicJiTUNES: http://apple.co/1xjWmlFCONNECT:TWITTER: https://twitter.com/RvTheory6INSTAGRAM: https://www.instagram.com/rvtheory6/THE UNION OF THE UNWANTED: https://linktr.ee/TheUnionOfTheUnwanted
Get to know a medical approach that allows patients to be evaluated outside their bodies. In this episode, I'm joined by Dr. Travis Craddock, who builds computer models of the brain and discusses how computational biology can help treat neuroinflammation. This approach utilizes mathematical equations and computer algorithms to simulate and describe how the brain functions with different interventions. In treating neuroinflammation in conditions such as myalgic encephalomyelitis (ME/CFS), Gulf War Illness (GWI), and Parkinson's disease, Dr. Craddock particularly looks at how the immune system works in the brain and how individual cells communicate and initiate inflammatory processes using specific rules and algorithms. While researchers and physicians work tirelessly to improve chronic illness treatment, don't be afraid to seek support for your health. Enjoy this episode? Don't forget to leave a 5-star review. Sign up for the 10-Day Cleanse Challenge here!
Join Haylie Pomroy, the Assistant Director of the Integrative Medicine Program, as she explores computational biology with our esteemed guest, Travis Craddock, Ph.D., an Associate Professor with expertise in Psychology, Neuroscience, Computer Science, and Clinical Immunology at Nova Southeastern University. Together, they talk about simulating brain functions, tailoring them to different health conditions, and testing potential treatments. Clinical researchers are bridging the gap between technology, biology, and holistic health. If you want to know more about how running various treatments in brain models will benefit you, listen to the full episode. Dr. Travis Craddock is an Associate Professor at Nova Southeastern University, where he directs the Clinical Systems Biology Group. His research focuses on using computational systems biology and biophysics methods to identify treatments for complex chronic illnesses involving neuroinflammation. He has a background in biophysics and has studied memory, consciousness, and cognitive dysfunction in neurodegenerative disorders. LinkedIn: https://www.linkedin.com/in/travis-craddock-30918978 —------------------------------------------------------------------------------------------------- Thank you for tuning in to the Hope and Help For Fatigue and Chronic Illness Podcast. Sign up today for our newsletter.
Dr. Jessica Rose is an artist, musician, mathematician, professional surfer, biologist, researcher, & data analysis. Dr. Rose has a Post Doc in Biochemistry at Technion Institute of Technology, Post Doc in Molecular Biology at Hebrew University of Jerusalem, PhD in Computational Biology at Bar Ilan University, Master's in Medicine (Immunology) at Memorial University of Newfoundland, and BSc in Applied Mathematics at Memorial University of Newfoundland.DR. JESSICA ROSE:Website: https://www.jessicasuniverse.com/Twitter: https://twitter.com/JesslovesMJKSubStack: https://jessicar.substack.com/YouTube: https://www.youtube.com/channel/UC0EhWf2Vswdg7DwKKKZ34ngTHE RIPPLE EFFECT PODCAST:WEBSITE: http://TheRippleEffectPodcast.comWebsite Host & Video Distributor: https://ContentSafe.co/SUPPORT:PATREON: https://www.patreon.com/TheRippleEffectPodcastPayPal: https://www.PayPal.com/paypalme/RvTheory6VENMO: https://venmo.com/code?user_id=3625073915201071418&created=1663262894MERCH Store: http://www.TheRippleEffectPodcastMerch.comMUSIC: https://music.apple.com/us/album/the-ripple-effect-ep/1057436436SPONSORS:LMNT Electrolyte Drink Mix (Free Gift With Purchase): http://DrinkLMNT.com/TheRippleEffectTHE UNIVERSITY OF REASON (Autonomy Course): https://www.universityofreason.com/a/29887/ouiRXFoLContentSafe: https://ContentSafe.co/WATCH:RUMBLE: https://rumble.com/c/c-745495ROKFIN: https://rokfin.com/RippleEffectYOUTUBE: https://www.youtube.com/channel/UCVfy9MXhb5EIciYRIO9cKUwLISTEN:SPOTIFY: https://open.spotify.com/show/4lpFhHI6CqdZKW0QDyOicJiTUNES: http://apple.co/1xjWmlFCONNECT:TeleGram: https://t.me/TREpodcastTWITTER: https://twitter.com/RvTheory6INSTAGRAM: https://www.instagram.com/rvtheory6/Facebook: https://www.facebook.com/TheRippleEffectPodcast/THE UNION OF THE UNWANTED: https://linktr.ee/TheUnionOfTheUnwanted
The Age of Prediction is such a fascinating book! After reading it, I really do think the job people should be preparing for is “data analyst” or “predictor”, because that's going to be used in every single industry, more than prompt engineers or AI coders - because AI is going to write its own code. Being able to understand what data to look at and why and how to make use of it, whether it's the medical industry or sports or stocks or insurance or art, this is going to be such a valuable skill to have, and it's a just beginning field. The creativity there is going to be amazing.The Age of Prediction: Algorithms, AI, and the Shifting Shadows of Risk by Christopher Mason and Igor Tulchinsky is like a guidebook to what's happened, what's going to be happening, and all the different ways people use will prediction technology.Igor has a $7 billion hedge fund, which analyzes millions of pieces of data around the world to predict stocks, whether something will happen tomorrow, or an hour from now, or 10 seconds from now.Christopher Mason is geneticist and computational biologist who has been a Principal Investigator and Co-investigator of many NASA missions and projects. I wanted to know: What is the state of this industry? How much can we really predict? How can we get better at it? What are the limitations? How close are we to manipulating DNA for disease gene removal? Can single-gene editing be done within a living human? We talk about all of that, and then just have a fun time while I pitched different ideas. Enjoy our interview with Igor and Chris, authors of The Age of Prediction.-----------What do YOU think of the show? Head to JamesAltucherShow.com/listeners and fill out a short survey that will help us better tailor the podcast to our audience!Are you interested in getting direct answers from James about your question on a podcast? Go to JamesAltucherShow.com/AskAltucher and send in your questions to be answered on the air!------------Visit Notepd.com to read our idea lists & sign up to create your own!My new book, Skip the Line, is out! Make sure you get a copy wherever books are sold!Join the You Should Run for President 2.0 Facebook Group, where we discuss why you should run for President.I write about all my podcasts! Check out the full post and learn what I learned at jamesaltucher.com/podcast.------------Thank you so much for listening! If you like this episode, please rate, review, and subscribe to “The James Altucher Show” wherever you get your podcasts: Apple PodcastsStitcheriHeart RadioSpotifyFollow me on Social Media:YouTubeTwitterFacebook
This holiday break, we're re-releasing two gorgeous beauty episodes from the Getting Curious archives! First up, join Dr. Tina Lasisi—a biological anthropologist studying human hair—and Jonathan as they explore the evolutionary history of hair, measuring hair variation, and the twists and turns of Jonathan's hair school textbook.Dr. Tina Lasisi is a Postdoctoral Researcher in Quantitative and Computational Biology at the University of Southern California, and incoming Assistant Professor of Anthropology at the University of Michigan. You can follow Dr. Lasisi on Instagram, Twitter, and TikTok @tinalasisi. Her website is www.tinalasisi.com. Make sure to check out more of her work via linktr.ee/tinalasisi, like her PBS Digital Studios series Why Am I Like This?. Want to support other Black Biological Anthropologists? Dr. Lasisi recommends following @BlackinBioAnthro on Twitter and Instagram, and @rockstaranthro on Instagram. Follow us on Instagram and Twitter @CuriousWithJVN to join the conversation. Jonathan is on Instagram and Twitter @JVN and @Jonathan.Vanness on Facebook. Transcripts for each episode are available at JonathanVanNess.com. Our executive producer is Erica Getto. Our associate producer is Zahra Crim. Our editor is Andrew Carson. Our theme music is “Freak” by QUIÑ; for more, head to TheQuinCat.com.